Search Results
Baxter Announces U.S. FDA Approval of Clinimix and Clinimix E with Higher Protein for Patients Requiring Parenteral Nutrition
A global leader in clinical nutrition, today announced the U.S. Food and Drug Administration (FDA) approval of new formulations of Clinimix (amino acids in dextrose) Injections and Clinimix E (amino acids with electrolytes in dextrose and calcium) Injections.
Baxter Announces Support for Finalization of Core Component of the Advancing American Kidney Health Initiative
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today issued this statement:
'I’m a Scientist... I Like Solving Problems'
Our technical leads generate data to make things happen
Baxter Announces Exclusive Distribution Agreement with bioMérieux for Novel Acute Kidney Injury Diagnostic Test in Europe and U.S.
Baxter International Inc. (NYSE:BAX), a global leader in acute care, today announced a distribution agreement with bioMérieux (EPA:BIM), a global leader in in vitro diagnostics, for the NEPHROCLEARTM CCL14 diagnostic test. The NEPHROCLEARTM CCL14 test is currently in development for use in assessing the risk of developing persistent severe acute kidney injury (AKI).
Baxter to Host Third-Quarter 2020 Financial Results Conference Call for Investors
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its third-quarter 2020 financial results on Thursday, October 29, 2020, at 7:30 a.m. Central Time.
Employing Expertise During a Pandemic
Our senior medical lead and infectious disease specialist discusses our Worldwide Medical team's response to COVID-19.
Baxter Announces U.S. FDA De Novo Authorization for Theranova Dialyzers Enabling HDx Therapy
Baxter International Inc. (NYSE:BAX), a global innovator in renal care, today announced the U.S. Food and Drug Administration (FDA) has granted the De Novo application for Theranova, the company’s novel dialysis membrane.
Carving Out a Career
From the beginning, electrical engineer has brought spark to Baxter
Baxter to Present at the Morgan Stanley Virtual 18th Annual Global Healthcare Conference
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the virtual Morgan Stanley 18th Annual Global Healthcare Conference via webcast on Wednesday, September 16, 2020. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 12:30 p.m. Eastern Time.
Baxter to Present at the Wells Fargo Virtual Healthcare Conference
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 2020 Wells Fargo Virtual Healthcare Conference via webcast on Wednesday, September 9, 2020. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 10:00 a.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through October 9, 2020.